Ren, Jun <br/><br/>
alpha2-Heremans Schmid glycoprotein, a putative inhibitor of tyrosine kinase, prevents glucose toxicity associated with cardiomyocyte dysfunction.  [electronic resource] 

 -  Diabetes/metabolism research and reviews   
 - 305-10 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1520-7552 
<br/><br/><label>Standard No.: </label>10.1002/dmrr.299  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Blood Proteins--pharmacology<br/>Cardiomyopathies--physiopathology<br/>Cells, Cultured<br/>Diabetic Angiopathies--physiopathology<br/>Enzyme Inhibitors--pharmacology<br/>Glucose--toxicity<br/>Heart--drug effects<br/>Heart Ventricles<br/>Insulin--pharmacology<br/>Male<br/>Muscle Cells--drug effects<br/>Myocardial Contraction--drug effects<br/>Phosphotyrosine--metabolism<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Rats<br/>Rats, Sprague-Dawley<br/>alpha-2-HS-Glycoprotein